•$Ouster (OUST.US)$+2.6% (announced a comprehensive cost reduction initiative across its business streamlining its cost structure and extending its expected cash runway)
•$Decibel Therapeutics (DBTX.US)$+2.3% (submission of an Investigational New Drug application for a Phase 1/2 clinical trial in pediatric patients of DB-OTO)
•$Boeing (BA.US)$+2.2% (met with regulators in China about returning 737 Max to flight according to Reuters)
•$Wave Life Sciences (WVE.US)$+2.1% (update to the ongoing Phase lb/2a SELECT-HD clinical trial of WVE-003 the company’s clinical candidate for Huntington's disease)
•$America Movil SAB de CV (AMX.US)$+1% (informs about the listing of Sitios Latinoamrica S.A.B. de C.V. incorporated as result of AMX's spin-off (Sitios Latam); also upgraded to Buy from Neutral at UBS)
•$Ford Motor (F.US)$-4.8% (reaffirms FY22 EBIT but inflation-related supplier costs to run $1 bln higher than expected)
Other news:
•$Invitae (NVTA.US)$-4.2% (reports real-world ciitizen data utilized in Praxis Precision Medicines' PR.AX-222 IND Filing) •$BioNTech (BNTX.US)$,$Moderna (MRNA.US)$– The vaccine makers are seeing shares fall again this morning, after sliding yesterday on President Joe Biden’s comment that the pandemic was "over."